Mobile Integrated Health vs a Transitions of Care Coordinator for Patients Discharged After Heart Failure
JAMA Internal Medicine · 2025
DOI: 10.1001/jamainternmed.2025.4483 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JAMA Internal Medicine, 2025. Verfasst von Ruth Masterson Creber und 21 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University School of Nursing, New York, New York. Hauptthemen laut MEDLINE: Heart Failure, Patient Discharge, Telemedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NHLBI NIH HHS, NINDS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Importance The comparative effectiveness of 2 transitions of care programs for improving health status and reducing readmissions among patients hospitalized with heart failure is unknown.
Objective
To compare the effectiveness adding mobile integrated health (MIH) to a transitions of care coordinator for improving health status and reducing 30-day all-cause readmissions among patients discharged after heart failure. Design, Settings, and Participants The Mighty-Heart randomized clinical trial included Medicare- or Medicaid-enrolled adult (≥18 years) patients hospitalized with heart failure in 11 New York City (New York) hospitals between January 2021 and September 2024. Participants were randomized 1:1 to MIH or TOCC. TOCC provided a follow-up call by a nurse 48 to 72 hours after discharge. MIH included the same TOCC postdischarge call, and added ongoing nurse care coordination, community paramedic home visits, and facilitated synchronous telehealth with emergency medicine physicians. Data analysis occurred between September 2024 and June 2025.
Interventions
Receiving MIH plus TOCC or TOCC alone during the first 30 days after hospital discharge. Main Outcomes and Measures Coprimary outcomes were health status at 30 days measured with the Kansas City Cardiomyopathy Questionnaire Overall Summary score, and 30-day all-cause hospital readmission, with heart failure-specific readmissions as a secondary outcome.
Results
Among 2003 participants (median [IQR] age, 67 [58-78] years; 1040 female [52%]), no adjusted differences were observed in the Kansas City Cardiomyopathy Questionnaire Overall Summary score at 30 days between MIH and TOCC groups (mean difference, 1.83; 95% CI, −0.75 to 4.40; P = .16). Exploratory analysis showed a significant age-by-treatment interaction effect, with younger participants who received MIH having larger improvement in health status (β: 4.40; 95% CI, 1.01 to 7.79). There were no significant differences in overall 30-day readmissions between study groups (20.3% vs 20.4%; odds ratio, 0.99; 95% CI, 0.83 to 1.19; P = .95). Conclusions and Relevance This randomized clinical trial found that MIH conferred no additional benefit on health status or 30-day readmissions for postacute patients with heart failure compared to TOCC alone. Preliminary subgroup analyses suggest potential variations in MIH effects by age and sex; therefore, further research is warranted. Trial Registration ClinicalTrials.gov Identifier: NCT04662541
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Columbia University School of Nursing, New York, New York.
- Departments of Emergency Medicine and Population Health Sciences, Weill Cornell Medicine, New York, New York.
- Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
- Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Medicine, Weill Cornell Medicine, New York, New York.
- Weill Cornell Medicine, New York, New York.
Förderung
- NINR NIH HHS
- NHLBI NIH HHS
- NINDS NIH HHS
Zitieren
APA
Masterson Creber, R., Daniels, B., Reading Turchioe, M., Shafran Topaz, L., Zhao, Y., Choi, J., Ellison, M., Merchant, R. C., Blutinger, E., Goyal, P., Yu, J., Weiner, M. G., Sholle, E., Ramasubbu, K., Alishetti, S., Axsom, K., Slotwiner, D., Rao, M., Diaz, I., …, & Kaushal, R. (2025). Mobile Integrated Health vs a Transitions of Care Coordinator for Patients Discharged After Heart Failure. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.4483
Vancouver
Masterson Creber R, Daniels B, Reading Turchioe M, Shafran Topaz L, Zhao Y, Choi J, et al. Mobile Integrated Health vs a Transitions of Care Coordinator for Patients Discharged After Heart Failure. JAMA Internal Medicine. 2025. doi:10.1001/jamainternmed.2025.4483
BibTeX
@article{MastersonCreber2025,
author = {Masterson Creber, Ruth and Daniels, Brock and Reading Turchioe, Meghan and Shafran Topaz, Leah and Zhao, Yihong and Choi, Jacky and Ellison, Melani and Merchant, Roland C and Blutinger, Erik and Goyal, Parag and Yu, Jiani and Weiner, Mark G and Sholle, Evan and Ramasubbu, Kumudha and Alishetti, Shudhanshu and Axsom, Kelly and Slotwiner, David and Rao, Maya and Diaz, Ivan and Spertus, John A and Sharma, Rahul and Kaushal, Rainu},
title = {Mobile Integrated Health vs a Transitions of Care Coordinator for Patients Discharged After Heart Failure},
journal = {JAMA Internal Medicine},
year = {2025},
doi = {10.1001/jamainternmed.2025.4483}
}
EUVIMED